GB0015736D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0015736D0
GB0015736D0 GBGB0015736.2A GB0015736A GB0015736D0 GB 0015736 D0 GB0015736 D0 GB 0015736D0 GB 0015736 A GB0015736 A GB 0015736A GB 0015736 D0 GB0015736 D0 GB 0015736D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0015736.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB0015736.2A priority Critical patent/GB0015736D0/en
Publication of GB0015736D0 publication Critical patent/GB0015736D0/en
Priority to PCT/EP2001/007079 priority patent/WO2002000708A2/en
Priority to AU2001285773A priority patent/AU2001285773A1/en
Priority to ARP010103045A priority patent/AR033378A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0015736.2A 2000-06-27 2000-06-27 Vaccine Ceased GB0015736D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0015736.2A GB0015736D0 (en) 2000-06-27 2000-06-27 Vaccine
PCT/EP2001/007079 WO2002000708A2 (en) 2000-06-27 2001-06-21 Mutants of prostase
AU2001285773A AU2001285773A1 (en) 2000-06-27 2001-06-21 Vaccine
ARP010103045A AR033378A1 (en) 2000-06-27 2001-06-26 DERIVATIVE OF ANTIGEN OF PROSTASE, NUCLEIC ACID SEQUENCE THAT CODIFIES IT, VECTOR OF EXPRESSION CONTAINING THE PREVIOUS, CELLULATED BONE TRANSFORMED WITH SUCH SEQUENCE OF A NUCLEIC ACID OR SUCH VECTOR, VACCINE THAT UNDERSTANDS THE NUMBER OF DERIVATIVE OF NUT USE OF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015736.2A GB0015736D0 (en) 2000-06-27 2000-06-27 Vaccine

Publications (1)

Publication Number Publication Date
GB0015736D0 true GB0015736D0 (en) 2000-08-16

Family

ID=9894505

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0015736.2A Ceased GB0015736D0 (en) 2000-06-27 2000-06-27 Vaccine

Country Status (4)

Country Link
AR (1) AR033378A1 (en)
AU (1) AU2001285773A1 (en)
GB (1) GB0015736D0 (en)
WO (1) WO2002000708A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786148A (en) * 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
US5955306A (en) * 1996-09-17 1999-09-21 Millenium Pharmaceuticals, Inc. Genes encoding proteins that interact with the tub protein
DE19805633A1 (en) * 1998-02-12 1999-08-19 Basf Ag New prostate serine protease
NZ509178A (en) * 1998-07-14 2004-04-30 Corixa Corp Compositions and methods for therapy and diagnosis of prostate cancer
JP2003504080A (en) * 1999-07-13 2003-02-04 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム vaccine

Also Published As

Publication number Publication date
AR033378A1 (en) 2003-12-17
WO2002000708A3 (en) 2002-05-16
AU2001285773A1 (en) 2002-01-08
WO2002000708A2 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
IL155282A0 (en) Vaccines
AU8189501A (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
AU1591402A (en) Vaccine
GB0130215D0 (en) Vaccine
GB0407935D0 (en) Vaccine
GB0024200D0 (en) Component vaccine
EP1423141A4 (en) Vaccine
GB0121171D0 (en) Vaccine
GB0014288D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
GB0025694D0 (en) Vaccine
GB0003082D0 (en) Vaccine
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
GB0004533D0 (en) Vaccines
GB0027433D0 (en) Vaccine component
GB0015935D0 (en) Vaccine
GB0005240D0 (en) Vaccine
GB0020693D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)